National Chemistry Week just wrapped, and in celebration, we’re shining a Dino-Mite Spotlight on Brock Shireman, our Head of Medicinal Chemistry. Brock shares his journey into the world of chemistry, the impact of mentorship, and even what he enjoys outside of work. Check it out and get inspired! #nationalchemistryweek #chemistry #science #ourpack #rapptors
Rapport Therapeutics
Biotechnology Research
Precision medicines to match the complexity of the human brain.
About us
Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.
- Website
-
http://www.rapportrx.com
External link for Rapport Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
Boston, Massachusetts, US
-
San Diego, California , US
Employees at Rapport Therapeutics
-
Karina Chmielewski
Chief Information Officer & Head of Operations at Rapport Therapeutics, Inc.
-
Gregg Keaney
Senior Vice President of CMC and Product Development at Rapport Therapeutics
-
Kathy Wilkinson
Chief People Officer
-
Tracey Coyle Grazio
Executive Support @ Rapport Therapeutics
Updates
-
Today is #GlobalDayAgainstPain. Rapport is proud to be working toward the next frontier in pain medicine to one day give patients a better quality of life, with two different pain programs currently in development. Our first pain program centers on peripheral neuropathic pain, a chronic condition caused by damaged or dysfunctional peripheral nerves, affecting millions of people worldwide. We’ll be evaluating our lead small molecule candidate RAP-219 in patients with this condition in an upcoming Phase 2a study. Our discovery stage pain program is more broadly focused on chronic pain indications, which may include neuropathic pain, inflammatory pain and more. Bradley Galer, Chief Medical Officer, offers thoughts below on the enormous unmet need that exists for those living with pain conditions as well as Rapport’s mission to improve patient lives and change health outcomes through the development of novel therapeutics. You can find more information on how Rapport is addressing pain on our website: https://bit.ly/3A5KFJp #PainManagement #Biotech
-
Yesterday, we honored the history and culture of Indigenous Peoples by donating to the Native American Health Center. The Native American Health Center is a nonprofit in the Bay Area dedicated to improving the health and wellbeing of California’s Native Population and other underserved communities – a meaningful cause that aligns with our belief in health equity and the importance of accessible healthcare for all. #IndigenousPeoplesDay #Community
-
Our CEO Abraham (Abe) Ceesay recently connected with Biotech2050 podcast host Rahul Chaturvedi to discuss all things biotech and – of course – Rapport. In the episode, Abe offers a deep dive on his career, what led him to take the helm at Rapport, how the company started, and how we’re working to bring to life a precision medicine approach in CNS and neuro disorders. Abe and Rahul covered a lot of ground, including Abe’s take on how to lead successfully, advice he’d have given his younger self, as well as his thoughts on the many different elements that need to come together to make an early-stage biotech successful. Check out the episode here: https://bit.ly/3A3JvxS #BiotechPodcast #Neuromedicine #CNSDisorders #BiotechInnovation #BostonBiotech #HealthcareInnovation
-
We’re taking a quick break from our everyday hustle for a guided meditation hosted by our very own Swamy Yeleswaram in recognition of World Mental Health Day. Let today serve as a reminder to check in on yourself and others, and to be KIND to YOU! #mentalhealth #worldmentalhealthday #meditation
-
We love when great ideas come from our people! To get to know each other better – across departments and locations – we’re matching Rapptors up with colleagues they don’t work with regularly. It’s then up to them to coordinate an in-person or virtual meetup over coffee or lunch, whatever works. We’re calling it Jurassic Java and so far, it has been a fun, casual way to bring people together. #jurassicjava #ourrapptors #culture #connections
-
Don’t miss David Bredt, our founder and CSO, at the SABPA San Diego BioPharma Conference in Del Mar on October 5. He’ll be talking about his journey from academia to developing precision medicines here at Rapport. With hundreds of academic and industry leaders converging at the conference, it’s going to be a great chance to discuss the latest breakthroughs in our field. If you’re in San Diego, we’d love to connect—hope to see you there! #Neuroscience #SanDiegoLifeSciences #DrugDevelopment #Biotechnology
-
Last week we had the privilege of speaking with Anne Fadiman, the author of The Spirit Catches You and You Fall Down. This complex story explores the cultural clash between Hmong refugees and the American medical system through the story of Lia Lee, a Hmong girl with epilepsy. This was our first read for our newly launched Book Club, and we’re so grateful we had the opportunity to connect with the author. Thank you, Anne for sharing your experience – your compassion was clear and your insight profound. And special shoutout to Allison Little for facilitating such a meaningful conversation. #bookclub #ourrapptors #companyculture
-
We’re celebrating Hispanic Heritage Month (September 15 – October 15) by shining a dino-mite spotlight on three of our Rapptors. Daniela Moreno is from Manizales, Colombia and is fluent in both Spanish and English. Martha Canto Bustos is from Mérida, Yucatán, Mexico and is known to bake a delicious traditional Pan de Muertos (Mexican Bread of the Dead). Gerardo Marquez was born and raised in the United States with his family origins in Mexico. In addition to tamales, some of Gerardo’s favorite Mexican dishes include birria, posole, and menudo. Thank you Daniela, Martha, and Gerardo for sharing your culture with us! #hispanicheritagemonth #ourrapptors
-
Stop by to see us today at the Epilepsy Foundation’s 2024 Pipeline Conference in Atlanta, Georgia. Gammaitoni Arnold, our SVP, Medical Affairs, will be there talking about our lead program RAP-219, including our Phase 2a trial in focal epilepsy. 30-40% of people living with epilepsy continue to have seizures despite taking multiple anti-seizure medications. We look forward to connecting at the conference with other trailblazers in the field as we work to change the paradigm for patients. #BostonBiotech #Neuromedicine #Epilepsy